CytomX Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
CytomX Therapeutics, Inc. has filed 794 SEC EDGAR filings since 28 Sep 2010

SEC filing history

Showing 551-575 of 794 matching filings.

Per page
25
Current page
23
4

FORM 4

Filing date
09 Jan 2018
Reporting date
05 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Jan 2018
Reporting date
05 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

FORM 8-K

Filing date
08 Jan 2018
Reporting date
08 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jan 2018
Reporting date
02 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jan 2018
Reporting date
02 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Dec 2017
Reporting date
26 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Dec 2017
Reporting date
15 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89140

SCHEDULE 13G

Filing date
18 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Dec 2017
Reporting date
08 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Dec 2017
Reporting date
01 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Dec 2017
Reporting date
01 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K

Filing date
04 Dec 2017
Reporting date
01 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K

Filing date
28 Nov 2017
Reporting date
28 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-37587

CT ORDER filing

Filing date
15 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K

Filing date
07 Nov 2017
Reporting date
07 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Nov 2017
Reporting date
01 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Nov 2017
Reporting date
01 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K

Filing date
24 Oct 2017
Reporting date
23 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
24 Oct 2017
Reporting date
23 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
24 Oct 2017
Reporting date
23 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Oct 2017
Reporting date
18 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Oct 2017
Reporting date
04 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Oct 2017
Reporting date
04 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Oct 2017
Reporting date
04 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .